Newly published research reveals that aberrant signaling by a protein called transforming growth factor-beta (TGF-beta - already known for its role in some connective tissue disorders) is also a potent player in many types of allergies.
Scientists have long understood that allergies are the result of a complex interplay between environment and genes, but now, in what investigators call a scientific first, a single genetic pathway has been implicated in an array of allergic disorders.